[Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor]. 1996

P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D001549 Benzamides BENZOIC ACID amides.

Related Publications

P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
January 1990, Farmakologiia i toksikologiia,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
January 1990, Farmakologiia i toksikologiia,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
January 1990, Farmakologiia i toksikologiia,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
December 1990, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
December 1989, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
May 1989, Biulleten' eksperimental'noi biologii i meditsiny,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
January 1990, Farmakologiia i toksikologiia,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
July 1968, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
June 1972, Die Medizinische Welt,
P A Galenko-Iaroshevskiĭ, and A I Khankoeva, and A V Uvarov, and A Iu Reznikov, and D S Galygo, and V V Bartashevich
January 1996, Klinicheskaia meditsina,
Copied contents to your clipboard!